Cargando…

Adherence status to Adjuvant Endocrine Therapy in Chinese Women with Early Breast Cancer and its influencing factors: A cross‐sectional survey

OBJECTIVE: Despite the proven benefits of adjuvant endocrine therapy, adherence to oral endocrine therapy in breast cancer treatment is a substantial problem. The aim of this study was to assess adherence to adjuvant endocrine therapy by women in China for the first 5 years, and to identify its infl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Hui, Jin, Feng, Zhang, Xiu‐jie, Wang, Da‐qiu, Yu, Shao‐fen, Wang, Ai‐ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286448/ https://www.ncbi.nlm.nih.gov/pubmed/32237070 http://dx.doi.org/10.1002/cam4.3017

Ejemplares similares

Current Status of Extended Adjuvant Endocrine Therapy in Early Stage Breast Cancer
por: van Hellemond, Irene E. G., et al.
Publicado: (2018)

Beliefs about medicines and adherence in women with breast cancer on adjuvant endocrine therapy
por: Tan, Eng Hooi, et al.
Publicado: (2021)

The relationship among psychosocial adaptation, medication adherence and quality of life in breast cancer women with adjuvant endocrine therapy
por: Jiang, Haoran, et al.
Publicado: (2022)

Oncologists’ perspectives on adherence/non-adherence to adjuvant endocrine therapy and management strategies in women with breast cancer
por: Eraso, Yolanda
Publicado: (2019)

Adherence to Adjuvant Endocrine Therapy in Breast Cancer Patients
por: Rosso, Roberta, et al.
Publicado: (2023)

Determinants of non-adherence to adjuvant endocrine treatment in women with breast cancer: the role of comorbidity
por: Wulaningsih, W., et al.
Publicado: (2018)

A survey of overall life satisfaction and its association with breast diseases in Chinese women
por: Bai, Aili, et al.
Publicado: (2015)

Status of adjuvant endocrine therapy for breast cancer
por: Schiavon, Gaia, et al.
Publicado: (2014)

Adjuvant endocrine therapy for premenopausal women with breast cancer: Patient adherence and physician prescribing practices in Mexico
por: Villarreal-Garza, Cynthia, et al.
Publicado: (2021)

Improved adjuvant endocrine therapy for premenopausal women with endocrine responsive disease
por: Goldhirsch, Aron, et al.
Publicado: (2015)

Relationships between determinants of adjuvant endocrine therapy adherence in breast cancer
por: Lee, Joo Yun, et al.
Publicado: (2018)

Informing interventions to improve uptake of adjuvant endocrine therapy in women with breast cancer: a theoretical-based examination of modifiable influences on non-adherence
por: Cahir, Caitriona, et al.
Publicado: (2023)

Breast Nurse Intervention to Improve Adherence to Endocrine Therapy Among Breast Cancer Patients in South Ethiopia
por: Getachew, Sefonias, et al.
Publicado: (2022)

Factors influencing five-year adherence to adjuvant endocrine therapy in breast cancer patients: A systematic review
por: Yussof, Izzati, et al.
Publicado: (2022)

Adherence to endocrine therapy among Chinese patients with breast cancer: current status and recommendations for improvement
por: Gao, Pin, et al.
Publicado: (2018)

Patient‐reported outcomes following neoadjuvant endocrine therapy, external beam radiation, and adjuvant continuous/intermittent endocrine therapy for locally advanced prostate cancer: A randomized phase III trial
por: Yokomizo, Akira, et al.
Publicado: (2021)

Prevalence and Determinants of Adherence to Oral Adjuvant Endocrine Therapy among Breast Cancer Patients in Singapore
por: Ali, Eskinder Eshetu, et al.
Publicado: (2017)

Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality
por: Makubate, B, et al.
Publicado: (2013)

Healthcare Provider Perspectives on Adherence to Adjuvant Endocrine Therapy after Breast Cancer
por: Lambert, Leah K., et al.
Publicado: (2021)

Interaction between glutathione S‐transferase M1‐null/present polymorphism and adjuvant chemotherapy influences the survival of breast cancer
por: Li, Shuang, et al.
Publicado: (2018)

Development of the HT&Me intervention to support women with breast cancer to adhere to adjuvant endocrine therapy and improve quality of life
por: Stewart, Sarah-Jane F., et al.
Publicado: (2023)

Soy intake and breast cancer risk: a prospective study of 300,000 Chinese women and a dose–response meta-analysis
por: Wei, Yuxia, et al.
Publicado: (2019)

Codevelopment of a Text Messaging Intervention to Support Adherence to Adjuvant Endocrine Therapy in Women With Breast Cancer: Mixed Methods Approach
por: Green, Sophie M C, et al.
Publicado: (2023)

Adjuvant endocrine therapy for premenopausal women with early breast cancer
por: Bao, Ting, et al.
Publicado: (2007)

Spatial distribution of mammography adherence in a Swiss urban population and its association with socioeconomic status
por: Sandoval, José Luis, et al.
Publicado: (2018)

Delayed initiation of adjuvant chemotherapy in older women with breast cancer
por: Smith‐Graziani, Demetria, et al.
Publicado: (2020)

Adjuvant endocrine therapy after breast cancer: a qualitative study of factors associated with adherence
por: Brett, Jo, et al.
Publicado: (2018)

Does patient health literacy impact adherence to adjuvant endocrine therapy in breast cancer patients?
por: Keim-Malpass, Jessica, et al.
Publicado: (2018)

Efficacy, immunogenicity, and safety of the HPV‐16/18 AS04‐adjuvanted vaccine in Chinese women aged 18–25 years: event‐triggered analysis of a randomized controlled trial
por: Zhu, Feng‐cai, et al.
Publicado: (2016)

Validation of the preoperative controlling nutritional status score as an independent predictor in a large Chinese cohort of patients with upper tract urothelial carcinoma
por: Xu, Hang, et al.
Publicado: (2018)

Mediterranean diet adherence and risk of colorectal cancer: the prospective Netherlands Cohort Study
por: Schulpen, Maya, et al.
Publicado: (2019)

DSCAM‐AS1 regulates the G(1)/S cell cycle transition and is an independent prognostic factor of poor survival in luminal breast cancer patients treated with endocrine therapy
por: Sun, Wei, et al.
Publicado: (2018)

Assessment and management of bone health in women with early breast cancer receiving endocrine treatment in the DATA study
por: van Hellemond, Irene E.G., et al.
Publicado: (2019)

Cognitive changes and brain connectomes, endocrine status, and risk genotypes in testicular cancer patients–A prospective controlled study
por: Buskbjerg, Cecilie R., et al.
Publicado: (2021)

Improving Adherence to Adjuvant Endocrine Therapy in Sub-Saharan Africa: Challenges and Innovative Nurse-Driven Solutions
por: Fadelu, Temidayo A, et al.
Publicado: (2022)

Racial Differences in Patient-Reported Symptoms and Adherence to Adjuvant Endocrine Therapy Among Women With Early-Stage, Hormone Receptor–Positive Breast Cancer
por: Hu, Xin, et al.
Publicado: (2022)

MLL3 is a de novo cause of endocrine therapy resistance
por: Stauffer, Kimberly M., et al.
Publicado: (2021)

Clinical and epidemiologic factors associated with breast cancer and its subtypes among Northeast Chinese women
por: Ye, Dong‐Man, et al.
Publicado: (2019)

The clinical efficacy and safety of kanglaite adjuvant therapy in the treatment of advanced hepatocellular carcinoma: A PRISMA-compliant meta-analysis
por: Liu, Jingjing, et al.
Publicado: (2019)

Predictive impact of the inflammation‐based indices in colorectal cancer patients with adjuvant chemotherapy
por: Tao, Yong, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_dv1ofa9ralkm7lar23l7cskl2o